Over the 90-day window ending December 12, 2025, Recursion Pharmaceuticals's three dominant insider ownership positions are held by TenPercentOwner Investment Co Pjsc Mubadala (12.99Mn shares), Director Blake Borgeson (6.87Mn shares), Director Dean Y Li (1.66Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Ventures Iv, L.P. Lux | 30,308,614 | 09 Dec, 2021 | |
| Investment Co Pjsc Mubadala | 12,985,927 | 03 Mar, 2023 | |
| Blake Borgeson | 6,869,863 | 04 Dec, 2025 | |
| Zachary Bogue | 3,736,341 | 06 Jul, 2023 | |
| Collective Iv, L.P. Data | 3,726,963 | 22 Apr, 2021 | |
| Dean Y Li | 1,659,528 | 03 Oct, 2025 | |
| Michael Secora | Chief Financial Officer | 1,487,694 | 19 Nov, 2024 |
| Christopher Gibson | Chief Executive Officer | 913,839 | 05 Dec, 2025 |
| Ben R Taylor | Chief Financial Officer | 789,990 | 26 Nov, 2025 |
| Najat Khan | Chief R&D Commercial Officer | 735,538 | 19 Nov, 2025 |
| Tina Marriott | President And COO | 506,852 | 19 Nov, 2024 |
| David J Mauro | Chief Medical Officer | 225,429 | 19 Nov, 2024 |
| Zavain Dar | 138,758 | 03 Oct, 2025 | |
| Shafique Virani | Chief Business Officer | 136,748 | 18 Jan, 2024 |
| Franziska Michor | 127,053 | 23 Jun, 2025 | |
| Ramona Doyle | Chief Medical Officer | 121,110 | 16 May, 2022 |
| Robert Hershberg | 73,732 | 23 Jun, 2025 | |
| Terry-Ann Burrell | 71,254 | 03 Jul, 2024 | |
| R. Martin Chavez | 60,078 | 03 Apr, 2024 | |
| Elaine D Sun | 47,557 | 23 Jun, 2025 | |
| Namandje Bumpus | 47,557 | 23 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Dec, 2025 | Christopher Gibson | Class A Common Stock | A | 60,000 | $0.00 | 973,839 | D | C |
| 04 Dec, 2025 | Christopher Gibson | Class A Common Stock | D | 40,000 | $4.63 | 933,839 | D | S |
| 04 Dec, 2025 | Christopher Gibson | Class A Common Stock | D | 20,000 | $0.00 | 913,839 | D | G |
| 02 Dec, 2025 | Blake Borgeson | Class A Common Stock | D | 220,000 | $4.37 | 6,869,863 | D | S |
| 25 Nov, 2025 | Ben R Taylor | Class A Common Stock | D | 2,271 | $4.03 | 789,990 | D | F |
| 17 Nov, 2025 | Christopher Gibson | Class A Common Stock | D | 40,390 | $4.14 | 913,839 | D | F |
| 17 Nov, 2025 | Ben R Taylor | Class A Common Stock | D | 11,908 | $4.14 | 792,261 | D | F |
| 17 Nov, 2025 | Najat Khan | Class A Common Stock | D | 17,584 | $4.14 | 735,538 | D | F |
| 19 Nov, 2025 | Christopher Gibson | Class A Common Stock | A | 40,000 | $0.00 | 953,839 | D | C |
| 19 Nov, 2025 | Christopher Gibson | Class A Common Stock | D | 40,000 | $4.16 | 913,839 | D | S |
| 05 Nov, 2025 | Najat Khan | Class A Common Stock | A | 84,925 | $0.00 | 753,122 | D | A |
| 04 Nov, 2025 | Christopher Gibson | Class A Common Stock | A | 60,000 | $0.00 | 1,014,229 | D | C |
| 04 Nov, 2025 | Christopher Gibson | Class A Common Stock | D | 40,000 | $5.21 | 974,229 | D | S |
| 04 Nov, 2025 | Christopher Gibson | Class A Common Stock | D | 20,000 | $0.00 | 954,229 | D | G |
| 23 Oct, 2025 | Christopher Gibson | Class A Common Stock | A | 100,000 | $0.00 | 1,054,229 | D | C |
| 23 Oct, 2025 | Christopher Gibson | Class A Common Stock | D | 100,000 | $5.70 | 954,229 | D | S |
| 10 Oct, 2025 | Christopher Gibson | Class A Common Stock | A | 120,000 | $0.00 | 1,074,229 | D | C |
| 10 Oct, 2025 | Christopher Gibson | Class A Common Stock | D | 100,000 | $6.04 | 974,229 | D | S |
| 10 Oct, 2025 | Christopher Gibson | Class A Common Stock | D | 20,000 | $0.00 | 954,229 | D | G |
| 01 Oct, 2025 | Dean Y Li | Class A Common Stock | A | 1,961 | $0.00 | 1,238,528 | D | A |